Klingman & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Klingman & Associates's AMGN Position: Q2 2026 in Review
Klingman & Associates increased its Amgen (AMGN) stake by 2.1% in Q2 2026, buying an estimated $14.7K and bringing the position to 2,140 shares worth $775K. The position accounts for 0.03% of the portfolio, ranked #166.
Klingman & Associates first reported a position in AMGN in Q4 2015 and has held it in 25 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Klingman & Associates held 2,140 shares of Amgen worth $775K as of Q2 2026.
- Klingman & Associates bought 43 Amgen shares in Q2 2026, an estimated $14.7K.
- Amgen made up 0.03% of Klingman & Associates's portfolio in Q2 2026, its #166 holding.
- Klingman & Associates first reported a position in Amgen in Q4 2015 and has held it in 25 quarters since.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Klingman & Associates's 13F filing for Q2 2026, filed 29 Jul 2026.